Drugs / Trivalent Inactivated Vaccine
last change Aug 2016 re-read 2 minutes ago

Trivalent Inactivated Vaccine

Vaccine

Developed for
influenza
Investigated by
Canadian Institutes of Health Research (CIHR) · McMaster University

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01653015 Nov 2012 → Jun 2015 influenza McMaster University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Trivalent Inactivated Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01653015
Modality Vaccine “inactivated influenza vaccine (IIV)” PMID 27538259 Aug 2016
Route Intramuscular “0.5 ml dose administered intramuscularly.” NCT01653015